About CERTs

Annual Report Year 4

AHRQ Letter | Steering Committee Letter | Introduction | CERTs Progress | Certs Program Resources | Certs Parnerships and Collaborations | Conclusion | The CERTs Organization | Principles of CERTs Public-Private Partnerships | Peer-Reviewed Publications

Peer-Reviewed Publications

October 2002- September 2003

Referenced Publications

• Katchman AN, McGroary KA, Kilborn MJ, Kornick CA, Manfredi PL, Woosley RL, Ebert SN. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K+ currents. J Pharmacol Exp Ther. 2002;303:688-694.
• Kornick CA, Kilborn MJ, Santiago-Palma J, Schulman G, Thaler HT, Keefe DL, Katchman AN, Pezzullo JC, Ebert SN, Woosley RL, Payne R, Manfredi PL. QTc interval prolongation associated with intravenous methadone. Pain. 2003;105:499-506.
• Curtis LH, Ostbye T, Sendersky V, Hutchison S, Allen LaPointe NM, Al-Khatib SM, Yasuda SU, Dans P, Wright A, Califf RM, Woosley RL, Schulman KA. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med. 2003;114:135-141.
• Peterson ED, Kaul P, Kaczmarek RG, Hammill BG, Armstrong PW, Bridges CR, Ferguson TB Jr, for the Society of Thoracic Surgeons. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol. 2003;42:1611-1616.
• Ray WA, Daugherty JR, Griffin MR. Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj Prev. 2002;8:276-279.
• Lautenbach E, Larosa LA, Kasbekar N, Peng HP, Maniglia RJ, Fishman NO. Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use. Arch Intern Med. 2003;163:601-605.
• Metlay JP, Shea JA, Asch DA. Antibiotic prescribing decisions of generalists and infectious disease specialists: thresholds for adopting new drug therapies. Med Decis Making. 2002;22:498-505.
• Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, Go AS, Smith D, Johnson CC, Kleinman K, Chan KA, Platt R. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003;112:620-627.
• Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003;163:2052-2057.
• Mudano AS, Casebeer L, Patino F, Allison JJ, Weissman NW, Kiefe CI, Person S, Gilbert D, Saag KG. Racial disparities in osteoporosis prevention in a managed care population. South Med J. 2003;96:445-451.
• Ray WA, Daugherty JR, Meador KG. Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy. N Engl J Med. 2003;348:1885-1894.
• Hennessy S, Bilker WB, Weber A, Zhou L, Brensinger C, Wang Y, Strom BL. Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA. 2003;290:1494-1499.

Additional Publications

• Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA. 2003;289:2120-2127.
• Al-Khatib SM, LaPointe NM, Curtis LH, Kramer JM, Swann J, Honig P, Califf RM. Outpatient prescribing of antiarrhythmic drugs from 1995 through 2000. Am J Cardiol. 2003;91:91-94.
• Butler J, Arbogast PG, BeLue R, Daugherty J, Jain MK, Ray WA, Griffin MR. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol. 2002;40:1589-1595.
• Califf RM, Peterson ED, Gibbons RJ, Garson A Jr, Brindis RG, Beller GA, Smith SC Jr., American College of Cardiology, American Heart Association. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol. 2002;40:1895-1901.
• Campbell WH, Califf RM. Improving communication about drug risks to prevent patient injury: proceedings of a workshop. Pharmacoepidemiol Drug Saf. 2003;12:183-194.
• Chan KA, Truman A, Gurwitz JH, Hurley JS, Martinson B, Platt R, Everhart JE, Moseley RH, Terrault N, Ackerson L, Selby JV. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med. 2003;163:728-734.
• Everett WW, Coffin SE, Zaoutis T, Halpern SD, Strom BL. Smallpox vaccination: a national survey of emergency health care providers. Acad Emerg Med. 2003;10:606-611.
• Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of colonization with vancomycin-resistant enterococcus in patients awaiting liver transplantation. Am J Transplant. 2003;3:902-905.
• Hennessy S, Bilker WB, Weber A, Strom BL. Descriptive analyses of the integrity of a US Medicaid claims database. Pharmacoepidemiol Drug Saf. 2003;12:103-111.
• LaPointe NM, Al-Khatib SM, Kramer JM, Califf RM. Knowledge deficits related to the QT interval could affect patient safety. Ann Noninvasive Electrocardiol. 2003;8:157-160.
• Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med. 2002;162:2469-2477.
• Lautenbach E, Larosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis. 2003;36:440-446.
• Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol. 2003;139:467-471.
• Liu X, Katchman A, Whitfield BH, Wan G, Janowski EM, Woosley RL, Ebert SN. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res. 2003;57:28-36.
• Localio AR, Berlin JA, Ten Have TR. Confounding due to cluster in multicenter studies-causes and cures. Health Services and Outcomes Research Methodology. 2002;3:195-210.
• Metlay JP, Hardy C, Strom BL. Agreement between patient self-report and a Veterans Affairs national pharmacy database for identifying recent exposures to antibiotics. Pharmacoepidemiol Drug Saf. 2003;12:9-15.
• Metlay JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother. 2003;51:963-970.
• M'ikantha NM, Southwell B, Lautenbach E. Automated laboratory reporting of infectious diseases in a climate of bioterrorism. Emerg Infect Dis. 2003;9:1053-1057.
• Mikuls TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ, Cerhan JR. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study. Ann Rheum Dis. 2002;61:994-999.
• Patino FG, Allison J, Olivieri J, Mudano A, Juarez L, Person S, Mikuls TR, Moreland L, Kovac SH, Saag KG. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs. Arthritis Rheum. 2003;49:293-299.
• Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet. 2002;360:1071-1073.
• Saag KG. Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin North Am. 2003;32:135-157.
• Stiles RA, So SA. Impact of transaction costs on healthcare outcomes. Expert Review of Pharmacoeconomics & Outcomes Research. 2003;3:283-291.

To Top